Similar articles

• Use of anabolic-androgenic steroids: we are talking prevalence rates.

  Kouri EM, Pope HG Jr, Katz DL. Kouri EM, et al. JAMA. 1994 Feb 2;271(5):347. JAMA. 1994. PMID: 8283582 No abstract available.
• Qualitative description of the prevalence and use of anabolic androgenic steroids by United States powerlifters.

  Curry LA, Wagman DF. Curry LA, et al. Percept Mot Skills. 1999 Feb;88(1):224-33. doi: 10.2466/pms.1999.88.1.224. Percept Mot Skills. 1999. PMID: 10214647
• Anabolic-androgenic steroids and adolescents: recent developments.

  Denham BE. Denham BE. J Addict Nurs. 2012 Oct;23(3):167-71, quuiz 172-3. doi: 10.1097/JAN.0b013e31826f4c3c. J Addict Nurs. 2012. PMID: 24335733
• Anabolic-androgenic steroid abuse and performance-enhancing drugs among adolescents.

  Bahrke MS, Yesalis CE, Brower KJ. Bahrke MS, et al. Child Adolesc Psychiatr Clin N Am. 1998 Oct;7(4):821-38. Child Adolesc Psychiatr Clin N Am. 1998. PMID: 9894044 Review.
• Incidence of the nonmedical use of anabolic-androgenic steroids.

  Yesalis CE, Anderson WA, Buckley WE, Wright JE. Yesalis CE, et al. NIDA Res Monogr. 1990;102:97-112. NIDA Res Monogr. 1990. PMID: 2079979 Review. No abstract available.